Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
JOHNSON & JOHNSON |
Market Closed -
Other stock markets
|
|
Pre-market 07:00:24 am | ||
| 158.88 USD | +0.32% | 157.64 | -0.78% | |
| 07:00am | Sanofi CEO under pressure to woo investors after spending shock | RE |
| Dec. 04 | Model N: A niche positioning |  |
Chart calendar Johnson & Johnson
49bbaa3cd71040c1c39d72f31.ePz0CxnQ6g9U6-32yM4XSRcEQovm2kiHYQZpwwyMJVs.Sba9elKVr0xgioCvoftaHGQ8KMyWjxDqCUsC90XGSREcr5leS-iQSwaHhg~090a4526f70aa8871af053e056833d4a
Upcoming events on Johnson & Johnson
Past events on Johnson & Johnson
| 2023-11-19 | U.S. Currency |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P199 |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P198 |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P175 |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P159 |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P158 |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P147 |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P115 |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P114 |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P110 |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P16 |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P18 |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P244 |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P243 |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P242 |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P225 |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P219 |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P200 |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P257 |
| 2023-10-31 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster Number : P256 |
Past dividends on Johnson & Johnson
| 2023-11-19 | Quarterly 1.19 USD |
| 2023-08-24 | Quarterly 1.19 USD |
| 2023-05-21 | Quarterly 1.19 USD |
| 2023-02-16 | Quarterly 1.13 USD |
| 2022-11-20 | Quarterly 1.13 USD |
| 2022-08-21 | Quarterly 1.13 USD |
| 2022-05-22 | Quarterly 1.13 USD |
| 2022-02-17 | Quarterly 1.06 USD |
| 2021-11-21 | Quarterly 1.06 USD |
| 2021-08-22 | Quarterly 1.06 USD |
Annual results
| Fiscal Period | January | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 81 581 81 416 0.2% | 82 059 82 193 -0.16% | 82 584 81 721 1.06% | 93 775 94 304 -0.56% | 94 943 95 017 -0.08% | 85 399 |
|
EBITDA Million USD | Released Forecast Spread | 28 104 29 996 -6.31% | 27 979 28 680 -2.45% | 27 145 27 951 -2.88% | 36 634 33 054 10.83% | 32 630 32 564 0.2% | 32 856 |
|
EBIT Million USD | Released Forecast Spread | 21 175 23 631 -10.39% | 25 593 25 615 -0.09% | 24 574 24 992 -1.67% | 29 244 30 088 -2.8% | 29 965 29 608 1.21% | 28 153 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 17 999 21 447 -16.08% | 17 328 19 476 -11.03% | 16 497 19 030 -13.31% | 22 776 24 759 -8.01% | 21 725 25 756 -15.65% | 22 660 |
|
Net income Million USD | Released Forecast Spread | 15 297 17 666 -13.41% | 15 119 16 943 -10.76% | 14 714 15 924 -7.6% | 20 878 22 542 -7.38% | 17 941 20 668 -13.19% | 18 647 |
|
EPS USD | Released Forecast Spread | 5,61 6,44 -12.89% | 5,63 6,47 -13.03% | 5,51 6,10 -9.72% | 7,81 8,42 -7.29% | 6,73 7,95 -15.29% | 7,45 |
| Announcement Date | 22/01/19 | 22/01/20 | 26/01/21 | 25/01/22 | 24/01/23 | - |
Quarterly results
| Fiscal Period | Enero | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 23 338 23 718 -1.6% | 24 804 25 289 -1.92% | 23 426 23 618 -0.81% | 24 020 23 825 0.82% | 23 791 23 433 1.53% | 23 706 23 901 -0.82% | 24 746 23 599 4.86% | 25 530 24 668 3.49% | 21 351 21 049 1.43% | 20 991 | 21 178 | 22 226 | 22 226 | 22 206 |
|
EBITDA Million USD | Released Forecast Spread | 9 639 8 389 14.91% | 7 939 7 408 7.17% | 9 305 8 964 3.8% | 9 011 8 659 4.07% | 9 299 8 682 7.11% | 7 804 7 485 4.26% | 8 880 8 484 4.66% | 8 912 8 671 2.78% | 8 071 7 683 5.04% | 7 239 | 8 070 | 8 305 | 8 573 | 7 749 |
|
EBIT Million USD | Released Forecast Spread | 7 825 7 625 2.62% | 6 096 6 790 -10.22% | 7 536 7 874 -4.29% | 7 267 7 763 -6.39% | 7 614 7 858 -3.1% | 7 093 6 702 5.83% | 8 204 7 411 10.7% | 8 189 7 753 5.62% | 7 374 6 967 5.83% | 6 289 | 7 182 | 7 409 | 7 484 | 7 011 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 4 836 5 551 -12.88% | 5 862 7 060 -16.97% | 5 840 6 856 -14.82% | 5 822 6 646 -12.4% | 4 201 6 020 -30.22% | -737 6 708 -110.99% | 6 762 7 242 -6.63% | 5 217 7 202 -27.56% | 5 042 | |||||
|
Net income Million USD | Released Forecast Spread | 3 667 6 189 -40.75% | 4 736 5 475 -13.5% | 4 458 5 921 -24.71% | 3 520 4 621 -23.82% | -68,0 5 573 -101.22% | 5 144 5 866 -12.3% | 26 028 | 4 130 | ||||||
|
EPS USD | Released Forecast Spread | 1,37 2,17 -36.72% | 1,77 1,91 -7.33% | 1,93 2,17 -11.06% | 1,80 2,19 -17.68% | 1,68 2,08 -19.36% | 1,33 1,87 -29% | -0,03 2,10 -101.43% | 1,96 1,89 3.45% | 10,2 2,17 370.51% | 1,86 | 2,25 | 2,38 | 2,33 | 2,23 |
| Announcement Date | 19/10/21 | 25/01/22 | 19/04/22 | 19/07/22 | 18/10/22 | 24/01/23 | 18/04/23 | 20/07/23 | 17/10/23 | - | - | - | - | - |
| 2024-01-07 | Q2 2024 Earnings Release (Projected) |
| 2024-01-10 | Q3 2023 Earnings Release |
| 2024-01-22 | Q3 2024 Earnings Release (Projected) |
| 2024-01-23 06:20 am | Q4 2023 Earnings Release |
| 2024-01-24 | Q3 2023 Earnings Release (Projected) |
| 2024-01-25 | Q4 2023 Earnings Release (Projected) |
| 2024-01-25 | Q3 2024 Earnings Release (Projected) |
| 2024-01-28 | Q3 2024 Earnings Release (Projected) |
| 2024-01-28 | Q3 2023 Earnings Release (Projected) |
| 2024-01-29 | Q4 2023 Earnings Release (Projected) |
Past sector events for Johnson & Johnson
| 2023-11-29 | Q3 2023 Earnings Release |
| 2023-11-27 | Q2 2024 Earnings Release |
| 2023-11-16 01:37 am | Q3 2023 Earnings Release |
| 2023-11-15 07:30 am | Q3 2023 Earnings Release |
| 2023-11-15 06:59 am | Q1 2024 Earnings Release |
| 2023-11-15 01:30 am | Q3 2023 Earnings Release |
| 2023-11-15 01:30 am | Q3 2023 Earnings Release |
| 2023-11-14 03:44 am | Q2 2024 Earnings Release |
| 2023-11-13 | Q3 2023 Earnings Release |
| 2023-11-13 07:00 am | Q2 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Johnson & Johnson - Nyse
- Calendar Johnson & Johnson
